Lennie Ryer
Director/Board Member at Aegera Therapeutics, Inc.
Profile
Lennie Ryer is currently a Director at Aegera Therapeutics, Inc. and a Member at Canadian Tax Foundation.
Previously, he worked as a Director at BANGI, Inc., CFO & Vice President-Finance at Paladin Labs, Inc., CFO & Vice President-Finance at ConjuChem Biotechnologies, Inc., Managing Partner at BDO Dunwoody LLP, CFO & Investor Relations Contact at SQI Diagnostics, Inc., Chief Financial Officer at Power Survey & Equipment Ltd., Chief Financial Officer at Meteorite Capital, Inc., and Chief Financial Officer & Vice President at Cannara Biotech, Inc. He was also the Chief Financial Officer at Group JS International Ltd.
Mr. Ryer received his undergraduate degree from McGill University.
Lennie Ryer active positions
| Companies | Position | Start |
|---|---|---|
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Director/Board Member | - |
| Canadian Tax Foundation | Corporate Officer/Principal | - |
Former positions of Lennie Ryer
| Companies | Position | End |
|---|---|---|
| CANNARA BIOTECH INC. | Director of Finance/CFO | 05/11/2020 |
Les Équipements Power Survey Ltée
 Les Équipements Power Survey Ltée Alternative Power GenerationUtilities Power Survey & Equipment Ltd. provides solutions for measuring and analyzing the intensity of harmonic currents and voltages. Its products include capacitor banks, harmonic filters, accessories and distribution. The firm offers power factor correction, harmonic distortion correction, start-up and commissioning, preventive maintenance, and technical training services for commercial and institutional, industrial and manufacturing, mining, metal and mineral, oil and gas, grid and transportation industries. The company was founded by 1948 and is headquartered in Montreal, Canada. | Director of Finance/CFO | 01/10/2017 |
| SQI DIAGNOSTICS INC. | Director of Finance/CFO | 15/02/2016 |
| Group JS International Ltd. | Director of Finance/CFO | 01/02/2015 |
ConjuChem Biotechnologies, Inc. /Old/
 ConjuChem Biotechnologies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ConjuChem Biotechnologies, Inc. develops peptide based pharmaceuticals to treat diseases such as congestive heart failure, diabetes, HIV/AIDS and human growth deficiencies. The company is a research and development company that develops technology that binds peptides to albumin in order to extend the half life of drugs from minutes to days. ConjuChem Biotechnologies is headquartered in Montréal , Canada. | Director of Finance/CFO | 31/08/2009 |
Training of Lennie Ryer
| McGill University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BANGI INC. | Health Technology |
| SQI DIAGNOSTICS INC. | Health Technology |
| CANNARA BIOTECH INC. | Process Industries |
| Private companies | 8 |
|---|---|
Paladin Labs, Inc.
 Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Paladin Labs Inc. operates as pharmaceutical company. It engages in developing, acquiring, in-licensing, marketing, and distributing innovative pharmaceutical products in Canada and internationally. The firm's products include Abstral, GlucaGen, Metadol, Plan B, Pennsaid, Seasonale, Testim, Twinject, Dexedrin, Tridural, and Trelstar. The company was founded by Jonathan Ross Goodman and Mark Beaudet on February 25, 1983 and is headquartered in Montreal, Canada. | Health Technology |
ConjuChem Biotechnologies, Inc. /Old/
ConjuChem Biotechnologies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ConjuChem Biotechnologies, Inc. develops peptide based pharmaceuticals to treat diseases such as congestive heart failure, diabetes, HIV/AIDS and human growth deficiencies. The company is a research and development company that develops technology that binds peptides to albumin in order to extend the half life of drugs from minutes to days. ConjuChem Biotechnologies is headquartered in Montréal , Canada. | Health Technology |
BDO Dunwoody LLP
 BDO Dunwoody LLP Miscellaneous Commercial ServicesCommercial Services Part of BDO LLP, BDO Dunwoody LLP is a Canadian company that provides accounting services. The private company is based in Toronto, Canada. | Commercial Services |
Aegera Therapeutics, Inc.
Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Health Technology |
| Canadian Tax Foundation | Miscellaneous |
Les Équipements Power Survey Ltée
Les Équipements Power Survey Ltée Alternative Power GenerationUtilities Power Survey & Equipment Ltd. provides solutions for measuring and analyzing the intensity of harmonic currents and voltages. Its products include capacitor banks, harmonic filters, accessories and distribution. The firm offers power factor correction, harmonic distortion correction, start-up and commissioning, preventive maintenance, and technical training services for commercial and institutional, industrial and manufacturing, mining, metal and mineral, oil and gas, grid and transportation industries. The company was founded by 1948 and is headquartered in Montreal, Canada. | Utilities |
Meteorite Capital, Inc.
 Meteorite Capital, Inc. Financial ConglomeratesFinance Meteorite Capital, Inc. is a capital pool company, which engages in identifying and evaluating of assets or a businesses with a view to complete a qualifying transaction. The company was founded on April 27, 2018 and is headquartered in Montréal, Canada. | Finance |
| Group JS International Ltd. |
- Stock Market
- Insiders
- Lennie Ryer
